Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05491213 · ClinicalTrials.gov registry record · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
A NA study of Lung Neoplasms, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 594
- Enrollment target
- 2
- Study locations
NCT05491213 is a NA study of Lung Neoplasms that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 594 participants, above the 440-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (35% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05491213, a NA study of Lung Neoplasms, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 594 participants
- Enrollment target
- 2
- Study locations
Study Summary
Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).
Conditions Studied
Interventions
- BEHAVIORAL TELESCOPE, Remote Decision Coaching with Navigation Intervention
Study Locations (2)
New Jersey
- Rutgers Cancer Institute - New Brunswick
Texas
- The University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05491213
The ClinicalTrials.gov registry entry for NCT05491213 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 440-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (35% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which TELESCOPE, Remote Decision Coaching with Navigation Intervention is the first listed.
NCT05491213 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Texas.
Frequently Asked Questions
What is clinical trial NCT05491213 about?
NCT05491213 is a clinical study titled "TELESCOPE- TELEhealth Shared Decision-making COaching". Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypo...
What is the current status of trial NCT05491213?
This trial is currently recruiting. It is a NA study. The enrollment target is 594 participants. The study started on 2023-02-14. Estimated completion is 2027-01-31.
What conditions does trial NCT05491213 study?
This clinical trial studies the following conditions: Lung Neoplasms.
What interventions are being tested in trial NCT05491213?
The interventions under investigation include: TELESCOPE, Remote Decision Coaching with Navigation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05491213?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05491213 being conducted?
This trial has 2 study locations across New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Specimen Banking From Patients With Lung Cancer
RECRUITING
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.